
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck
View Full LandscapeTarget Indication
Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck
Clinical Trial
NCT02319044Last updated: 3/17/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Hypercholesterolemia
Generalized Anxiety Disorder
Metastatic Castration-resistant Prostate Cancer
Healthy Japanese Children Age 2 Years Through 6 Years
Metastatic Castration-resistant Prostate Cancer